Becton, Dickinson and Company (NYSE:BDX) Price Target Raised to $290.00
Becton, Dickinson and Company (NYSE:BDX – Free Report) had its price target raised by Evercore ISI from $286.00 to $290.00 in a research note released on Tuesday morning, Benzinga reports. The firm currently has an outperform rating on the medical instruments supplier’s stock. BDX has been the topic of a number of other research reports. […]
5 Oct 22:49 · The Markets Daily